866-997-4948(US-Canada Toll Free)

Global Parkinsons Disease (PD) Drugs Market 2017-2021

Published By :

Technavio

Published Date : Aug 2017

Category :

Therapeutic Area

No. of Pages : 85 Pages

About Parkinson's Disease (PD) Drugs

Parkinsons disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra. This lowers the concentration of dopamine in the striatum by 80%. This decrease in dopamine levels leads to symptoms associated with PD such as tremors, bradykinesia, and muscular rigidity. It is usually diagnosed after the age of 50 years; however, cases of earlier incidence have also been reported.

Technavios analysts forecast the global parkinson's disease (PD) drugs market to grow at a CAGR of 3.81% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global parkinson's disease (PD) drugs market for 2017-2021. To calculate the market size, the report considers sales/revenues and market share of the PD drugs.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Parkinson's Disease (PD) Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries

Other prominent vendors
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Prana Biotechnology
Reviva Pharmaceuticals
SK Biopharmaceuticals
Takeda Pharmaceutical
UCB

Market driver
Rise in geriatric population
For a full, detailed list, view our report

Market challenge
Entry of generics
For a full, detailed list, view our report

Market trend
Emergence of biomarkers
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Pipeline landscape
PART 07: Market segmentation by drug class
Dopamine agonist
MAO inhibitors
AChE inhibitors
Glutamate inhibitors
Others
PART 08: Market segmentation based on geography
PD drugs market in Americas
PD drugs market in EMEA
PD drugs market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Emergence of biomarkers
Gene therapy to reverse the progression of PD
Advancing biomedical science
Focus on regenerative therapies for mental disorders
High growth potential of mAbs
PART 12: Vendor landscape
Competitive scenario
Key news
PART 13: Key vendor analysis
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
Other prominent vendors
PART 14: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Global PD drugs market: A snapshot
Exhibit 02: Global PD drugs market 2016-2021 ($ millions)
Exhibit 03: Opportunity analysis of global PD drugs market
Exhibit 04: Five forces analysis
Exhibit 05: Pipeline landscape based on number of molecules, 2016
Exhibit 06: Key clinical trials
Exhibit 07: Segmentation of global PD drugs market by drug class 2016
Exhibit 08: Global PD drugs market share by drug class 2016
Exhibit 09: Global PD dopamine agonist drugs market 2016-2021 ($ millions)
Exhibit 10: Global PD MAO inhibitors drugs market 2016-2021 ($ millions)
Exhibit 11: Global PD AchE inhibitors drugs market 2016-2021 ($ millions)
Exhibit 12: Global PD glutamate inhibitors drugs market 2016-2021 ($ millions)
Exhibit 13: Segmentation of global PD drugs market share by geography 2016 and 2021 (%)
Exhibit 14: Global PD drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 15: Global PD drugs market share by geography 2016-2021 (%)
Exhibit 16: PD drugs market scenario in different regions
Exhibit 17: Market scenario in Americas
Exhibit 18: PD drugs market in Americas 2016-2021 ($ millions)
Exhibit 19: Market scenario in EMEA
Exhibit 20: PD drugs market in EMEA 2016-2021 ($ millions)
Exhibit 21: Market scenario in APAC
Exhibit 22: PD drugs market in APAC 2016-2021 ($ millions)
Exhibit 23: Geriatric population analysis and estimates in 2000 and 2030 (millions)
Exhibit 24: Revenue erosion of PD drugs after loss of exclusivity
Exhibit 25: Planned clinical trials of iPS cell-based therapies
Exhibit 26: Competitive structure analysis of global PD drugs market 2016
Exhibit 27: Boehringer Ingelheim: Key highlights
Exhibit 28: Boehringer Ingelheim: Strength assessment
Exhibit 29: Boehringer Ingelheim: Strategy assessment
Exhibit 30: Boehringer Ingelheim: Opportunity assessment
Exhibit 31: GlaxoSmithKline: Key highlights
Exhibit 32: GlaxoSmithKline: Strength assessment
Exhibit 33: GlaxoSmithKline: Strategy assessment
Exhibit 34: GlaxoSmithKline: Opportunity assessment
Exhibit 35: Novartis: Key highlights
Exhibit 36: Novartis: Strength assessment
Exhibit 37: Novartis: Strategy assessment
Exhibit 38: Novartis: Opportunity assessment
Exhibit 39: Teva Pharmaceutical Industries: Key highlights
Exhibit 40: Teva Pharmaceutical Industries: Strength assessment
Exhibit 41: Teva Pharmaceutical Industries: Strategy assessment
Exhibit 42: Teva Pharmaceutical Industries: Opportunity assessment

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *